Global Consortium to Advance Data on the Epidemiology and Health Impacts of Illicit Drug Use

Professor

Adjunct Senior Lecturer

Program Lead, Drug Trends

Adjunct Lecturer

Director

Honorary Professor

We have developed a multidisciplinary global consortium of researchers who can provide independent high-quality evidence regarding the scale of illicit drug use, harms, access to services at country, regional and global levels, and build capacity for better data in these areas.

The work by this group includes a range of reviews and synthesis of evidence, including:

Systematic review of country-level, regional and global estimates of prevalence of injecting drug use; sociodemographic and risk characteristics of people who inject drugs; and HIV, HCV and HBV prevalence amongst people who inject drugs

To access the journal article please visit .
Interactive dashboards containing data from this study are available on the .

Systematic review of country-level, regional and global estimates of coverage of needle-syringe programme, opioid substitution therapy, HIV testing, anti-retroviral therapy, and condom programmes for people who inject drugs.

To access the journal article please visit .
Interactive dashboards containing data from this study are available on the .

Project Collaborators External

Dr Janni Leung University of Queensland
A/Prof Jason Grebely Kirby Institute
Prof Matt Hickman University of Bristol
Prof Peter Vickerman University of Bristol
Prof John Strang King's College London
Prof Michael Lynskey King's College London
Prof John Marsden King's College London
Dr Lindsey Hines King's College London
Mr Jack Stone University of Bristol
Mr Adam Trickey University of Bristol
Mr Evan Cunningham Kirby institute
Prof Wayne Hall University of Queensland
Mr Konstantin Dumchev Ukrainian Institute on Public Health Policy
Mr Paul Griffiths EMCDDA
Prof Jurgen Rehm CAMH

Project Supporters

Open Society Foundations; The Global Fund; WHO; UNAIDS; United Nations Office on Drugs and Crime; Australian National Drug and Alcohol Research Centre, UNSW Sydney

Researchers from the Consortium have been involved in initiatives that have had major impacts at a global, regional and national level. This includes key researchers involved with the Global Burden of Disease project, the WHO’s World Mental Health Survey. This work has informed global, regional and country-level policies.

In September 2015 the UN General Assembly adopted 17 Sustainable Development Goals (SDGs) under the 2030 Agenda for Sustainable Development. These included multiple targets relevant to people who use illicit drugs. The Agenda emphasizes the need for transparent, critical monitoring of progress, creating a need for independent scientific advice.

This Consortium will function to fill this gap, drawing together researchers who have established and collaborated on large-scale global health initiatives to provide independent scientific advice for improved epidemiological data, advances in modelling estimates, and work on indicators for measuring SDG progress.

Our aim is to maximise independent high-quality evidence regarding the scale of illicit drug use, harms, access to services at country, regional and global levels, and build capacity for better data in these areas.

Three major functions:

Advice regarding data and methodological developments related to estimates of alcohol and drug use and intervention and treatment coverage
Work to improve estimates of drug-attributable burden
Develop links with leading research institutions in other countries, with a focus on academic units in less resourced countries to improve data, and generation of new data

Design and Method

Two global reviews are currently in progress, comprising:

Systematic review of country-level, regional and global estimates of prevalence of injecting drug use among people aged 15-64 years; sociodemographic and risk characteristics of people who inject drugs; and HIV and viral prevalence amongst people who inject drugs.
Systematic review of country-level, regional and global estimates of coverage of needle-syringe programme, opioid substitution therapy, HIV testing, anti-retroviral therapy, and condom programmes for people who inject drugs.

Please email any queries regarding these projects, or any updated city/sub-national/country level estimates of the above to global.reviews@unsw.edu.au